Connie L Celum MD

Professor, Global Health and Community Medicine, University of Washington School of Medicine

325 9th AveSeattle, WA 98104
Phone+1 206-744-3000

Dr. Celum is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Celum's full profile Already have an account?

Education & Training

University of WashingtonFellowship, Infectious Disease, 1989 - 1991
University of California San Francisco School of MedicineClass of 1984, MD

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1985 - Present
WA State Medical License 1987 - 2026
American Board of Internal Medicine Internal Medicine

Clinical Trials

A Study of the Effects of Advantage 24 on the Rectum
COMPLETED
PHASE1
A Study of HIV in Newly Infected Individuals
COMPLETED
A Study to Monitor the Health of Participants in HIVNET 014 Who Become Infected With HIV-1
COMPLETED

Publications & Presentations

PubMed

1 citations
High prevalence and incidence of curable sexually transmitted infections among young women using oral HIV pre-exposure prophylaxis in sub-Saharan Africa: results from ...
Irene Mukui, Sue Peacock, Deborah Donnell, Brenda Gati-Mirembe, Meighan Krows
Sexually Transmitted Infections. 2026-08-18
Acceptability and use of doxyPEP among cisgender men who have sex with men, transgender women and non-binary persons assigned male sex at birth: results from a nationa...
Nathanael Leon Gistand, Thiago S Torres, Connie Celum, Annie Luetkemeyer, Susan Buchbinder
Sexually Transmitted Infections. 2026-07-02
Men's preferences for HIV self-test distribution strategies in Uganda: A discrete choice experiment.
Shiven Bhardwaj, Jackson Mugisha, Julius Magembe, George Eram, Agnes Nakyanzi
Journal of Acquired Immune Deficiency Syndromes. 2026-06-26

Journal Articles

Covid-19, Ebola, and HIV — Leveraging Lessons to Maximize Impact
Connie Celum, Myron S Cohen, Wafaa El-Sadr, The New England Journal of Medicine
Quadrivalent HPV Vaccine in HIV-1-Infected Early Adolescent Girls and Boys in Kenya: Month 7 and 12 Post Vaccine Immunogenicity and Correlation with Immune Status
Linda Eckert, Connie Celum, Jared M Baeten, ScienceDirect
Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships
Elizabeth R Brown, Jessica E Haberer, Connie Celum, Jared M Baeten, AIDS and Behavior

Press Mentions

"Glimmer of Hope": STI Surge Shows First Signs of Slowing in Decades. What’s Behind the Trend?January 17th, 2025
Widely Available Antibiotic Helps Prevent Bacterial STIs in Certain Populations, UW Clinical Trial FindsJune 6th, 2022
Young Women and Pregnant Women Can Effectively Use Vaginal Rings and Oral PrEP for HIV PreventionJuly 28th, 2021

Grant Support

The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratiosUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
The Doxy-PEP Impact Study: a multi-city US longitudinal cohort to evaluate doxy-PEP field effectiveness, investigate associated antimicrobial resistance, and establish doxy-PEP to need ratiosUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
University of Washington/Fred Hutch Center for AIDS ResearchUNIVERSITY OF WASHINGTON1997–2028
University of Washington/Fred Hutch Center for AIDS ResearchUNIVERSITY OF WASHINGTON1997–2028
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with menUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2019–2025